Free Trial

Humana (HUM) Competitors

$351.80
-3.63 (-1.02%)
(As of 06/7/2024 08:52 PM ET)

HUM vs. ELV, CI, CNC, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE

Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Elevance Health (ELV), The Cigna Group (CI), Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.

Humana vs.

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation.

89.2% of Elevance Health shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 0.4% of Elevance Health shares are held by company insiders. Comparatively, 0.3% of Humana shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.0%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Humana pays out 22.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years and Humana has increased its dividend for 7 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana received 47 more outperform votes than Elevance Health when rated by MarketBeat users. However, 66.80% of users gave Elevance Health an outperform vote while only 64.01% of users gave Humana an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
837
66.80%
Underperform Votes
416
33.20%
HumanaOutperform Votes
884
64.01%
Underperform Votes
497
35.99%

Elevance Health has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.34B0.73$5.99B$26.4620.37
Humana$106.37B0.40$2.49B$16.0621.91

In the previous week, Humana had 25 more articles in the media than Elevance Health. MarketBeat recorded 40 mentions for Humana and 15 mentions for Elevance Health. Humana's average media sentiment score of 1.01 beat Elevance Health's score of 0.41 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
9 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
10 Very Positive mention(s)
0 Positive mention(s)
26 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.82%. Humana's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
Humana 1.82%17.76%5.63%

Elevance Health currently has a consensus target price of $601.64, suggesting a potential upside of 11.63%. Humana has a consensus target price of $423.63, suggesting a potential upside of 20.42%. Given Elevance Health's higher probable upside, analysts clearly believe Humana is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
3.00
Humana
0 Sell rating(s)
12 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.43

Summary

Elevance Health beats Humana on 16 of the 22 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$42.39B$64.89B$5.27B$17.91B
Dividend Yield1.01%1.35%2.77%3.56%
P/E Ratio21.9121.78137.3825.05
Price / Sales0.400.542,448.4514.20
Price / Cash10.279.9935.7119.35
Price / Book2.653.964.994.99
Net Income$2.49B$3.04B$110.97M$975.94M
7 Day Performance-1.76%-2.29%-1.09%-1.87%
1 Month Performance5.12%0.63%-0.96%-1.65%
1 Year Performance-31.46%10.91%4.12%9.19%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.7582 of 5 stars
$540.43
-0.4%
$601.64
+11.3%
+14.6%$125.61B$171.34B20.42104,900Positive News
CI
The Cigna Group
4.9445 of 5 stars
$337.06
-0.9%
$373.87
+10.9%
+27.2%$97.01B$195.27B27.6772,500
CNC
Centene
4.8335 of 5 stars
$70.13
-1.4%
$84.93
+21.1%
+1.2%$37.96B$154.00B13.9467,700Positive News
MOH
Molina Healthcare
4.9722 of 5 stars
$307.71
-0.9%
$407.45
+32.4%
+9.0%$18.19B$34.07B16.70123,123Positive News
UNH
UnitedHealth Group
4.8065 of 5 stars
$505.49
+1.6%
$572.75
+13.3%
-0.6%$457.84B$371.62B30.90440,000Dividend Increase
OSCR
Oscar Health
2.3397 of 5 stars
$18.93
-1.5%
$18.57
-1.9%
+110.0%$4.56B$5.86B-47.322,400
ALHC
Alignment Healthcare
2.6572 of 5 stars
$7.85
-1.8%
$9.20
+17.2%
+17.5%$1.50B$2.01B-9.351,536Positive News
TRUP
Trupanion
2.3155 of 5 stars
$28.76
+2.3%
$32.80
+14.0%
+10.1%$1.18B$1.11B-44.941,142Gap Down
CLOV
Clover Health Investments
1.9099 of 5 stars
$1.11
-5.1%
$1.50
+35.1%
+10.0%$580.83M$2.03B-3.26552
NEUE
NeueHealth
1.4083 of 5 stars
$5.88
-1.2%
$8.00
+36.1%
N/A$48.33M$1.16B-0.041,252Negative News
Gap Down

Related Companies and Tools

This page (NYSE:HUM) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners